Категории

Cellular and targeted therapies for Hodgkin lymphoma

Опубликовано: 14 Октябрь 2024
на канале: VJHemOnc – Video Journal of Hematology & HemOnc
178
2

Here, Pauline Brice, MD, PhD, of Hopital Saint-Louis, Paris, France, talks about the new targeted and cellular therapies for Hodgkin lymphoma. Dr Brice was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

play_arrow
27
1

Empowering Senior Citizens: Webinar Recap on Health, Wellness, and Technology. Silverwings

Empowering Senior Citizens: Webinar Recap on Health, Wellness, and Technology. Silverwings
play_arrow
106
6

Dog dance in the snow ⛄️

Dog dance in the snow ⛄️

play_arrow
49,740
1.9 тыс

Gypsy Dance on 1 String + TUTORIAL

Gypsy Dance on 1 String + TUTORIAL
play_arrow
50
0

Bird's nest removal, at end of season. Empty nest, time to remove them.

Bird's nest removal, at end of season. Empty nest, time to remove them.
play_arrow
1,390
12

DIY Honda Genio Knuckle Bearing Installation

DIY Honda Genio Knuckle Bearing Installation
play_arrow
10
0

Edifying Stories from My Journey Following Jesus, Part 1

Edifying Stories from My Journey Following Jesus, Part 1
play_arrow
9
0

RGT Silversurfer G4 2021 South

RGT Silversurfer G4 2021 South
play_arrow
51
5

Ep04 Ship found, let’s get ready for action; 500% Solo wealth independent; RimWorld royalty

Ep04 Ship found, let’s get ready for action; 500% Solo wealth independent; RimWorld royalty
Похожие видео
play_arrow
Acquired von Willebrand disease in Waldenström’s macroglobulinemia: diagnosis and treatment

Acquired von Willebrand disease in Waldenström’s macroglobulinemia: diagnosis and treatment
play_arrow
Adverse events associated with BTKis in the treatment of Waldenström’s macroglobulinemia

Adverse events associated with BTKis in the treatment of Waldenström’s macroglobulinemia
play_arrow
WM-NET: upcoming clinical trials to advance the treatment of WM

WM-NET: upcoming clinical trials to advance the treatment of WM
play_arrow
Multi-omic analysis in WM: progress being made and challenges that remain

Multi-omic analysis in WM: progress being made and challenges that remain
play_arrow
A Phase II study investigating epcoritamab in the treatment of Waldenström’s macroglobulinemia

A Phase II study investigating epcoritamab in the treatment of Waldenström’s macroglobulinemia
play_arrow
The evolving role of genomics in the treatment of WM: MYD88, CXCR4, and TP53

The evolving role of genomics in the treatment of WM: MYD88, CXCR4, and TP53
play_arrow
The potential of fixed-duration BTKis and using MRD to guide treatment discontinuation in WM

The potential of fixed-duration BTKis and using MRD to guide treatment discontinuation in WM
play_arrow
Multi-omics studies to understand the progression from premalignant states to WM

Multi-omics studies to understand the progression from premalignant states to WM
play_arrow
Hyperviscosity syndrome as a complication in WM and its management with plasma exchange

Hyperviscosity syndrome as a complication in WM and its management with plasma exchange
play_arrow
Ibrutinib plus rituximab in symptomatic Japanese patients with Waldenström's macroglobulinemia

Ibrutinib plus rituximab in symptomatic Japanese patients with Waldenström's macroglobulinemia
play_arrow
The diverse presentation of symptoms in patients with Waldenström's macroglobulinemia

The diverse presentation of symptoms in patients with Waldenström's macroglobulinemia
play_arrow
The role of the microenvironment and stromal components in WM progression and drug resistance

The role of the microenvironment and stromal components in WM progression and drug resistance